Seeking Alpha


Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Small-cap biotechs scorched [View news story]
    GALE has been particularly hit hard in the last trading sessions. However, this company has incredible potential and has already proved it. I don't know why people freak out. You didn't expect to be green all the time did you? GALE may go lower, perhaps into the mid $4s but it won't matter when Abstral sales and NeuVax drive it to $12 +, and based on its track record, it will. Finally, for those of us who bought GALE more than a year ago, we have, at least, doubled our investment. Look at the science behind it and not at the crisis in the emerging markets. GALE is a BUY. Whoever disagrees, show me the numbers to prove otherwise.
    Jan 27, 2014. 05:29 PM | 2 Likes Like |Link to Comment
1 Comment